Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 5 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 5 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 8 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

AI Process Discovers, Tests Fibrosis Drug in 18 Months

Human lungs illustration

A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease. . . . → Read More: AI Process Discovers, Tests Fibrosis Drug in 18 Months

Large Trial Testing Covid-19 Antibody Therapies

Global Covid-19

A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections. . . . → Read More: Large Trial Testing Covid-19 Antibody Therapies

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy

Infographic – Global Climate Technology Hubs

Chart: climate tech hubs

The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Five Covid-19 Vaccines in Clinical Trials

Coronavirus face mask

A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage. . . . → Read More: Five Covid-19 Vaccines in Clinical Trials

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response